Subject: FDA Approves Wider Use Of PCP Drug 566 
Date: Published: 11/13/91 (30 lines)
Source:  Wall Street Journal.  Copyright Dow Jones & Co. Inc. 

    Business Brief -- Wellcome PLC:
    FDA Approves Wider Use
    Of a Drug Against AIDS

    Burroughs Wellcome Co. said the Food and Drug
 Administration authorized wider use of its experimental drug
 566, used for treatment of pneumocystic carinii pneumonia in
 people with AIDS.  
    The oral medication will be made available free of charge
 under a Treatment IND procedure, which permits a drug company
 to distribute a potentially life-saving drug to some patients
 while clinical trails of the medicine are under way.
    Burroughs Wellcome, a U. S. unit of the British drug
 company Wellcome PLC, said 566 will be made available to
 people who have mild to moderate pneumocystic carinii
 pneumonia and have trouble with other therapies.  PCP is a
 potentially deadly ailment that often accompanies AIDS.  
    The medication is a new, broad-spectrum anti-parasitic
 drug originally synthesized by the Wellcome Research
 Laboratories as an anti-malarial and subsequently shown to
 have activity against AIDS-related pneumonia.  The company
 also sells the anti-viral drug AZT.  

[This article is made available here by Dow Jones Co. for the
 personal and non-commercial use of callers to this bbs, in the
 hope that it will be of some help to those who are suffering
 from the disease and others who are seeking to help them.]